# Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

> **NCT01955161** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 933 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Idalopirdine

## Key facts

- **NCT ID:** NCT01955161
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 933 (ACTUAL)
- **Last updated:** 2017-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955161, "Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01955161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*